NCT05731154

Brief Summary

This study was conducted to develop an AI solution to evaluate clinical activity score (CAS) of thyroid associated orbitopathy (TAO) using periocular selfie images taken by smartphones in patients with thyroid dysfunction. An AI solution to evaluate CAS in TAO was developed in previous retrospective study using periorbital digital images taken by DSLR camera in the studio. This AI solution will be adjusted to show its best performance with periocular selfie images taken by smartphones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 22, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 17, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2022

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

February 16, 2023

Completed
Last Updated

February 16, 2023

Status Verified

February 1, 2023

Enrollment Period

7 months

First QC Date

April 17, 2022

Last Update Submit

February 15, 2023

Conditions

Keywords

thyroid eye diseaseartificial intelligencemachine learningsmartphone

Outcome Measures

Primary Outcomes (2)

  • Accuracy for clinical activity score (CAS) of thyroid eye disease (TED)

    Accuracy of AI solution using smartphone selfie images for CAS of TED.

    baseline (this study has no intervention)

  • Diagnostic accuracy for active thyroid eye disease

    Accuracy of AI solution using smartphone selfie images for active thyroid eye disease (TED) which is defined as 3 or more of clinical activity score

    baseline (this study has no intervention)

Secondary Outcomes (5)

  • Accuracy for redness of eyelids

    baseline (this study has no intervention)

  • Accuracy for redness of conjunctiva

    baseline (this study has no intervention)

  • Accuracy for swelling of eyelids

    baseline (this study has no intervention)

  • Accuracy for swelling of conjunctiva

    baseline (this study has no intervention)

  • Accuracy for swelling of caruncle

    baseline (this study has no intervention)

Study Arms (1)

thyroid eye disease group

Patients who were diagnosed as thyroid eye disease. Periorbital images are taken by DSLR camera in the studio. Periorbital selfie images are taken by the patients with 6 smartphones including various camera modules. CAS of TAO is evaluated by 3 ophthalmologists based on the periorbital digital images taken by DSLR camera and symptoms.

Other: taking periorbital selfie images using smartphones

Interventions

taking periorbital selfie images using smartphones

thyroid eye disease group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study is conducted to develop AI solution using smartphone selfie images. Therefore, the number of subjects for this study was calculated as 200, the maximum number of patients with thyroid eye disease that can be prospectively recruited during the study period.

You may qualify if:

  • Patients with thyroid eye disease

You may not qualify if:

  • Patients who have prior facial anomaly or surgery
  • Patients who cannot use smartphone camera app

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13620, South Korea

Location

MeSH Terms

Conditions

Graves Ophthalmopathy

Condition Hierarchy (Ancestors)

Eye Diseases, HereditaryEye DiseasesGraves DiseaseExophthalmosOrbital DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGoiterThyroid DiseasesEndocrine System DiseasesHyperthyroidismAutoimmune DiseasesImmune System Diseases

Study Officials

  • Namju Kim, MD, PhD.

    Seoul National University Bundang Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 17, 2022

First Posted

February 16, 2023

Study Start

December 22, 2021

Primary Completion

July 18, 2022

Study Completion

July 25, 2022

Last Updated

February 16, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

IPD will not be shared.

Locations